Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	81.20B
Revenue (ttm)	20.87B
Net Income (ttm)	4.62B
Shares Out	103.44M
EPS (ttm)	41.50
PE Ratio	14.74
Forward PE	17.19
Dividend	14.00 (1.78%)
Ex-Dividend Date	Jun 20, 2025

Volume	4,026,683
Average Volume	1,095,806
Open	790.00
Previous Close	785.00
Day's Range	789.00 - 863.00
52-Week Range	562.00 - 975.00
Beta	0.61
RSI	62.87
Earnings Date	Aug 11, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.